Purchase
Description
Rituxan® (rituximab) is a genetically engineered chimeric murine/human monoclonal IgG1 kappa antibody directed against the CD20 antigen. Rituximab has an approximate molecular weight of 145 kD. Rituximab is produced by mammalian cell (Chinese Hamster Ovary) suspension culture in a nutrient medium containing the antibiotic gentamicin. Gentamicin is not detectable in the final product.
Rituximab is a sterile, clear, colorless, preservative-free liquid. Rituximab is supplied at a concentration of 10 mg/Ml, which contains polysorbate 80 (0.7 mg/mL), sodium chloride (9 mg/mL), sodium citrate dihydrate (7.35 mg/mL), and Water for Injection. The pH is 6.5.
Properties
|
Name
|
Rituximab
|
|
CAS
NO.
|
174722-31-7
|
|
Type
|
Whole
antibody
|
|
Source
|
Chimeric(mouse/human)
|
|
Target
|
CD20
|
|
Clone
|
Monoclone
|
|
Formula
|
C6416H9874N1688O1987S44
|
|
Molecular
Weight
|
145 kDa
|
|
Antibody
Form
|
Purified immunoglobulin
|
|
Physical
Form
|
Solution
|
|
Grade
Standard
|
Medicine Grade
|
|
Place
of Origin
|
China(Mainland)
|
|
Storage
|
-70±15℃ for long-term storage,
2-8℃ for short-term storage, away from light.
|
Supply Ability
20 kilogram per year, Minimum order quantity is 1 gram.
Price
Inquiry
Material Safety Data Sheet
If you need more information, please contact us.
Certificate Of Analysis
/en/UploadFile/file/201805/20180508155038693869.rar
Detail information about the product please refer the website below：
https://en.wikipedia.org/wiki/Rituximab
|
